SPDL1 and COVID-19: In conclusion, our findings suggest that sTIM-3 and sPD-L1 may operate in different ways at the onset of COVID-19 to enhance a dysfunctional and exaggerated inflammatory response, which may be helpful for distinguishing patients requiring IMV.